Brain Implant for Depression Approved for Human Testing by FDA
Original: A Brain Implant for Depression Is About to Be Tested in Humans
Why This Matters
First FDA-approved brain implant trial for depression could revolutionize mental health treatment
Motif Neurotech received FDA approval to test a blueberry-sized brain implant that delivers electrical stimulation to treat depression. The Houston startup targets treatment-resistant patients using wireless technology and a charging cap for home use.
The FDA approved human trials for Motif Neurotech's brain implant targeting depression treatment. The device implants in the skull above the brain's protective membrane, stimulating the central executive network that's underactive in major depression. Unlike competitors like Neuralink focusing on paralysis, Motif targets mental health. The 20-minute outpatient procedure requires no brain surgery. Patients wear a baseball cap to charge the wireless device and receive 10-20 minute treatments several times daily. Nearly 3 million Americans have treatment-resistant depression from 9 million total cases. CEO Jacob Robinson expects patients to show response within 10 days, compared to current TMS therapy requiring 30 treatments over six weeks.